EFFECTIVENESS OF ABROCITINIB TREATMENT IN PATIENTS WITH DIFFICULT-TO-TREAT ATOPIC DERMATITIS: DAILY PRACTICE DATA

被引:0
|
作者
Olydam, Jill [1 ]
Schlosser, Anne [1 ]
Custurone, Paolo [1 ]
Nijsten, Tamar [1 ]
Hijnen, Dirkjan [1 ]
机构
[1] Erasmus MC, Dept Dermatol, Rotterdam, Netherlands
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
P10.3
引用
收藏
页码:51 / 51
页数:1
相关论文
共 50 条
  • [41] Thoughtful prescribing for patients with difficult-to-treat depression
    Soubolsky, Amy
    Visentin, Jessica
    Crawley, Alex
    [J]. CANADIAN FAMILY PHYSICIAN, 2023, 69 (11) : E221 - E228
  • [42] AIH: Which Alternative for Difficult-to-Treat Patients?
    Sebode, Marcial
    Schramm, Christoph
    [J]. DIGESTIVE DISEASES, 2015, 33 : 83 - 87
  • [43] LONG-TERM ASSESSMENT OF THE BURDEN OF ATOPIC SENSITIZATION IN PATIENTS WITH SEVERE/DIFFICULT-TO-TREAT ASTHMA
    Zeiger, R.
    Chipps, B.
    Ortiz, B.
    Kianifard, F.
    Paknis, B.
    Haselkorn, T.
    Foreman, A.
    Szefler, S.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S58 - S59
  • [44] The management of patients with difficult-to-treat multiple myeloma
    Richter, Joshua
    Ramasamy, Karthik
    Rasche, Leo
    Blade, Joan
    Zweegman, Sonja
    Davies, Faith
    Dimopoulos, Meletios
    [J]. FUTURE ONCOLOGY, 2021, 17 (16) : 2089 - 2105
  • [45] COPING WITH DIFFICULT-TO-TREAT CANCER-PATIENTS
    HYLAND, JM
    NOVOTNY, ES
    COYNE, L
    TRAVIS, JW
    PRUYSER, H
    [J]. BULLETIN OF THE MENNINGER CLINIC, 1984, 48 (04) : 329 - 341
  • [46] Treating hepatitis C in "difficult-to-treat" patients
    Pawlotsky, JM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05): : 422 - 423
  • [47] Predominance of Atopic Asthma in Patients with Severe or Difficult-to-Treat Asthma in the TENOR-II cohort
    Haselkorn, Tmirah
    Mink, David
    Kianifard, Farid
    Ortiz, Benjamin
    Paknis, Brandee
    Lecocq, Jason
    Chipps, Bradley E.
    Bleecker, Eugene R.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : 593 - +
  • [48] Abrocitinib attenuates the systemic inflammatory profile in patients with atopic dermatitis
    Del Duca, E.
    Kim, M.
    Da Rosa, J. Correa
    Pulsinelli, J.
    Estrada, Y.
    Chan, G.
    Chen, A.
    Xu, D.
    Guler, E.
    Page, K.
    Kerkmann, U.
    Guttman-Yassky, E.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S48 - S48
  • [49] Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the Bioday registry
    Ariens, L. F.
    Van der Schaft, J.
    Bakker, D. S.
    Balak, D.
    Romeijn, M.
    Kouwenhoven, T.
    Kamsteeg, M.
    Giovannone, B.
    Knol, E. F.
    Drylewicz, J.
    Van Wijk, F.
    Nierkens, S.
    Thijs, J. L.
    Schuttelaar, M.
    De Bruin-Weller, M. S.
    [J]. ALLERGY, 2019, 74 : 581 - 582
  • [50] Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry
    Ariens, Lieneke F. M.
    van der Schaft, Jorien
    Bakker, Daphne S.
    Balak, Deepak
    Romeijn, Margreet L. E.
    Kouwenhoven, Tessa
    Kamsteeg, Marijke
    Giovannone, Barbara
    Drylewicz, Julia
    van Amerongen, Cynthia Catalina Aurora
    Delemarre, Evelien M.
    Knol, Edward F.
    van Wijk, Femke
    Nierkens, Stefan
    Thijs, Judith L.
    Schuttelaar, Marie L. A.
    de Bruin-Weller, Marjolein S.
    [J]. ALLERGY, 2020, 75 (01) : 116 - 126